Trial Profile
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied Drug/Drug Interaction (DDI) Probe Compounds
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Intarcia Therapeutics
- 21 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 08 Jan 2016 New trial record